Phreesia Inc

Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Phreesia reports strong Q1 earnings, sees growth in Medicare market

Phreesia's Q1 2023 earnings call highlighted strong performance, maintained revenue outlook, and raised adjusted EBITDA outlook. The company faces challenges from labor market changes and pricing experimentation but sees opportunities in product growth, client adds, and patient insights application.

Phreesia reports strong Q2 2024 earnings and strategic acquisitions

Phreesia's Q2 2024 performance reflects strong revenue growth and strategic outlook, despite challenges related to client adds and subscription revenue. The company's focus on achieving profitability beyond fiscal 2025 and strategic acquisitions positions it for long-term value creation. Balancing growth and investment, as well as navigating seasonality and external events, are key considerations for Phreesia's future.

Phreesia reports Q3 2024 revenue of $91.6 million, delays revenue target to prioritize EBITDA growth

Phreesia's Q3 2024 earnings call highlighted strong revenue performance, an acquisition enhancing patient experience, and a strategic decision to delay revenue targets to prioritize EBITDA growth. The company maintains a focus on innovation, customer satisfaction, and sustainable financial performance, while also addressing short-term financial challenges and positioning for significant revenue and profitability growth in fiscal 2025.

Phreesia reports robust Q4 earnings, eyes growth in healthcare solutions

Phreesia Inc's Q4 2023 performance reflects strong revenue growth and client base expansion, positioning the company for future profitability and stability.
With a focus on client value, strategic acquisitions, and operational efficiency, Phreesia navigates challenges in the healthcare industry to drive long-term growth.
Opportunities in network solutions, payer space, and margin improvement present avenues for Phreesia to capitalize on market trends and enhance shareholder value.

Phreesia Inc reports strong Q1 earnings, eyes revenue growth

Phreesia Inc's Q1 2024 performance reflects robust revenue growth and client expansion, with a positive outlook for fiscal 2024 and ambitious targets for fiscal 2025.
While facing challenges such as potential growth deceleration and labor market impacts, the company remains focused on innovation, client satisfaction, and profitability.
Opportunities in new revenue streams, partnerships, and payment technologies present avenues for Phreesia to drive future growth and market leadership.

Phreesia Inc reports robust Q2 performance and targets fiscal growth

Phreesia Inc's Q2 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic targets for fiscal 2024 and 2025, underpinned by investments in client value and growth strategies.
While facing challenges in the sales cycle and cost controls, the company remains focused on achieving profitability and free cash flow without additional capital beyond fiscal '25.
Opportunities in product introductions, customer service enhancements, and market expansion present avenues for sustained growth and value creation for Phreesia.

Phreesia reports robust Q3 performance, shifts focus to profitability

Phreesia Inc's Q3 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic acquisitions, underlining the company's positive trajectory.
While facing challenges in achieving profitability and managing investor expectations, Phreesia's focus on financial discipline and market expansion presents opportunities for sustainable growth.
The establishment of a new credit facility and clear guidance for fiscal 2024 and 2025 demonstrate Phreesia's commitment to financial stability and long-term value creation.

Phreesia reports strong Q4 revenue growth and focuses on profitability

Phreesia Inc's Q4 performance reflects revenue growth and improved EBITDA, with a focus on efficiency and client value to drive profitability.
Despite industry challenges, Phreesia's strengths in client growth strategies, network solutions revenue, and cash flow support its growth trajectory.
Balancing profitability goals with investments in growth, Phreesia navigates challenges while exploring opportunities in PAM, client value, and network expansion.
The company's outlook for FY 2025 underscores a commitment to sustainable growth through client additions, product enhancements, and operational efficiency.

Phreesia Inc reports strong Q1 earnings, eyes growth opportunities

Phreesia Inc's Q1 performance reflects a positive turnaround with revenue growth and adjusted EBITDA turning positive after 3 years. The company faces challenges from client relationship transitions but is leveraging opportunities in cybersecurity investments and revenue-driving products.

Phreesia Inc reports robust Q2 earnings and optimistic outlook

Phreesia Inc's Q2 2025 earnings call highlighted strong financial performance and positive outlook for fiscal 2025. While facing uncertainties around external factors and inorganic opportunities, the company remains focused on driving growth through AHSC expansion and revenue enhancement strategies.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Founders-led PHR has been adding clinics and patients to its ecosystem. The newly added clinics are smaller in scale, signaling the end of rapid market penetration.

Phreesia - Healthcare Ecosystem At An Attractive Valuation

Phreesia, Inc. (NYSE:PHR ) Q3 2023 Earnings Conference Call December 8, 2022 5:00 PM ET Company Participants Balaji Gandhi - SVP, IR Chaim Indig - CEO & Co-Founder Randy Rasmussen - CFO Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Stephanie Davis - SVB Securities Glen Santangelo - Jefferies Daniel Grosslight - Citi John Ransom - Raymond James Scott Schoenhaus - KeyBanc Joe Vruwink - Baird Ryan MacDonald - Needham Robert Simmons - D.A. Davidson Operator Good evening, ladies and gentlemen, and welcome to the Phreesia Fiscal Third Quarter 2023 Earnings Conference Call.

Phreesia, Inc. (PHR) Q3 2023 Earnings Call Transcript

WILMINGTON, Del.--( BUSINESS WIRE )--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the third quarter ended October 31, 2022.

Phreesia Announces Third Quarter Fiscal 2023 Results

WILIMINGTON, Del.--( BUSINESS WIRE )--Phreesia is proud to announce that Sara DiNardo, the company's Vice President of Client Solutions, has been named to The Software Report's list of the Top 50 Women Leaders in SaaS of 2022.

Phreesia's Sara DiNardo Selected as a Top Woman Leader in SaaS

Phreesia Sets Release Date for Fiscal Third Quarter 2023 Results

The average of price targets set by Wall Street analysts indicates a potential upside of 25.7% in Phreesia (PHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Can Phreesia (PHR) Climb 26% to Reach the Level Wall Street Analysts Expect?

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has named Alexandra Beneville as Vice President of Life Sciences Content Strategy. Beneville officially joined Phreesia on Aug. 1, 2022, from Phosphorus, a direct-to-consumer genomic testing company, where she had served as Vice President of Marketing since December 2021. In her new role, Beneville will oversee the Phreesia Life Sciences Content Strategy team, spearheading its digital patient engag

Phreesia Names Alexandra Beneville Vice President of Life Sciences Content Strategy

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Quality Forum (NQF)'s Measure Applications Partnership (MAP) 2022-2023 Clinician Workgroup. NQF convened MAP in 2011, in partnership with the Centers for Medicare & Medicaid Services (CMS), to provide input to the U.S. Department of Health and Human Services (HHS) on the selection of performance meas

Phreesia's Zeeshan Butt Named to NQF's MAP Clinician Workgroup

Phreesia, Inc. (NYSE:PHR ) Q2 2023 Results Conference Call September 7, 2022 5:00 PM ET Company Participants Balaji Gandhi - Senior Vice President, Investor Relations Chaim Indig - Chief Executive Officer and Co-Founder Randy Rasmussen - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Glen Santangelo - Jefferies Ryan Daniels - William Blair Richard Close - Canaccord Genuity Matt Shea - Needham Stephanie Davis - SVB Securities Daniel Grosslight - Citi Jessica Tassan - Piper Sandler Jack Wallace - Guggenheim Joe Vruwink - Baird Joe Goodwin - JMP Securities John Ransom - Raymond James Operator Good morning, ladies and gentlemen, and welcome to the Phreesia Fiscal Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Phreesia, Inc. (PHR) Q2 2023 Earnings Call Transcript

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2022. "I am extremely proud of our team's accomplishments in the second quarter of fiscal year 2023. Phreesia impacts more than one in 10 patient visits in the U.S. each day1, helping patients become more activated in their health and achieve better health outcomes," said CEO and Co-Founder Chaim Indig. "Our strong network and re

Phreesia Announces Fiscal Second Quarter 2023 Results

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2023 financial results after the close of market trading on Wednesday, September 7, 2022. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter resul

Phreesia Sets Release Date for Fiscal Second Quarter 2023 Results

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that it has been named to The Software Report's list of “The Top 100 Software Companies of 2022.” The annual award recognizes the best companies leading the software industry forward, considering criteria including product quality, organizational effectiveness and management caliber. This year, The Software Report placed particular emphasis on companies' environmental, social and governance (ESG) engagement in their evaluation, giv

Phreesia Named to The Software Report's “Top 100 Software Companies of 2022”

After losing some value lately, a hammer chart pattern has been formed for Phreesia (PHR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Here's Why Phreesia (PHR) Is a Great 'Buy the Bottom' Stock Now

The mean of analysts' price targets for Phreesia (PHR) points to a 37.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts See a 38% Upside in Phreesia (PHR): Can the Stock Really Move This High?

Healthcare ecosystem management platform developer Phreesia (NYSE: PHR) stock is sunk (-40%) on the year.

Phreesia Stock is a Healthcare IT Play

The consensus price target hints at a 25.5% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wall Street Analysts Think Phreesia (PHR) Could Surge 26%: Read This Before Placing a Bet

RALEIGH, N.C.--(BUSINESS WIRE)--Patients' expectations of healthcare technology are changing to reflect the digital conveniences they are used to in other aspects of their lives, according to research in a newly published white paper from Phreesia. Based on the results of a survey of 4,136 patients, the paper sheds light on the consumer-centric trends reshaping healthcare delivery and shares best practices that healthcare organizations can employ to improve patients' experience and better engag

New Phreesia Research Reveals Patients' Changing Preferences for their Digital Healthcare Experience

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is proud to announce that Hilary Hatch, PhD, the company's Chief Clinical Officer, has been selected to participate in the National Quality Forum (NQF)'s 2022 Leadership Consortium. Dr. Hatch's inclusion in this expert group underscores Phreesia's commitment to improving patients' healthcare experiences and outcomes by enabling them to become more active participants in their care. The Leadership Consortium is a prestigious and exclusive forum of multist

Phreesia's Hilary Hatch Named to the NQF 2022 Leadership Consortium

NEWBURY PARK, Calif. & RALEIGH, N.C.--(BUSINESS WIRE)--Compulink Healthcare Solutions, a leader in specialty-specific all-in-one EHR solutions; and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce that they have partnered to offer a robust, bidirectional integration between their systems. This integration will help practices save time, increase patient collections, improve patient satisfaction, and keep their schedules full. Practices using Phreesia and Com

Compulink and Phreesia Partner to Help Practices Increase Efficiency and Profitability with an Integrated Intake Solution

Phreesia, Inc. (NYSE:PHR ) Q1 2023 Earnings Conference Call June 2, 2022 5:00 PM ET Company Participants Balaji Gandhi - Senior Vice President, Investor Relations Chaim Indig - Chief Executive Officer and Co-Founder Randy Rasmussen - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler John Ransom - Raymond James Joe Vruwink - Robert W. Baird Glen Santangelo - Jefferies Richard Close - Canaccord Genuity Ryan MacDonald - Needham Stephanie Davis - SVB Leerink Joe Goodwin - JMP Securities Jack Wallace - Guggenheim Operator Good afternoon.

Phreesia, Inc. (PHR) CEO Chaim Indig on Q1 2023 Results - Earnings Call Transcript

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2022. “We started the year strong with gains in new clients and expansion within existing clients across healthcare services and life sciences and began to generate operating leverage from our accelerated investments in fiscal years 2021 and 2022,” said CEO and Co-Founder Chaim Indig. Fiscal First Quarter 2023 Highlights Revenue

Phreesia Announces Fiscal First Quarter 2023 Results

Phreesia (PHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Phreesia (PHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

SALT LAKE CITY & RALEIGH, N.C.--(BUSINESS WIRE)--KLAS, a healthcare research and insights firm, and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce the release of a report that aims to shed light on patients' preferences and expectations for the technology they interact with as a part of their healthcare experience. The report is the result of a survey designed to better understand patient sentiments on a range of topics, including how they like to schedul

KLAS and Phreesia Partner to Deliver Patient Insights on Healthcare Technology

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is excited to announce it has been selected by Becker's Healthcare as one of this year's 150 Top Places to Work in Healthcare. The list highlights hospitals, health systems and healthcare companies that promote diversity within the workforce, employee engagement and professional growth. “We're thrilled to receive this recognition of our commitment to maintaining a diverse, inclusive and equitable environment that supports employee growth and success,” sa

Phreesia Named One of Becker's Healthcare's “150 Top Places to Work in Healthcare”

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is excited to announce it has been selected by Modern Healthcare as one of the 2022 Best Places to Work in Healthcare. This is the sixth time Phreesia has been named to the list. “We are proud to be included on this prestigious list once again,” said Phreesia CEO Chaim Indig. “With our team of remote workers located across the country, this honor is a testament to our ability to stay connected with our colleagues and clients, and to our talented and hard

News for Phreesia Inc Stock (PHR)